IP Verse

Stable Liquid Fibrinogen - EP3481415

The patent EP3481415 was granted to Laboratoire Franais DU Fractionnement ET DES Biotechnologies on Sep 6, 2023. The application was originally filed on Jul 6, 2017 under application number EP17742825A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3481415

LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Application Number
EP17742825A
Filing Date
Jul 6, 2017
Status
Granted And Under Opposition
Aug 4, 2023
Grant Date
Sep 6, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BIOTESTJun 5, 2024TER MEER STEINMEISTER & PARTNERADMISSIBLE
TAKEDA PHARMACEUTICALSJun 5, 2024HOFFMANN EITLEADMISSIBLE
MARCHANTMay 24, 2024MURGITROYDADMISSIBLE

Patent Citations (39) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP1648496
DESCRIPTIONEP1739093
DESCRIPTIONWO0017234
DESCRIPTIONWO0017239
DESCRIPTIONWO0021568
DESCRIPTIONWO2010019847
DESCRIPTIONWO2012090183
DESCRIPTIONWO2015136217
EXAMINATIONEP1393741
EXAMINATIONEP1568709
EXAMINATIONFR2857267
EXAMINATIONUS7550567
EXAMINATIONWO2010019847
EXAMINATIONWO2015136217
EXAMINATIONWO2018007530
INTERNATIONAL-SEARCH-REPORTEP1393741
INTERNATIONAL-SEARCH-REPORTFR2857267
INTERNATIONAL-SEARCH-REPORTUS7550567
INTERNATIONAL-SEARCH-REPORTWO2010019847
INTERNATIONAL-SEARCH-REPORTWO2015136217
OPPOSITIONAU2015228649
OPPOSITIONEP1393741
OPPOSITIONFR2857267
OPPOSITIONJP3867931B
OPPOSITIONUS2006247426
OPPOSITIONUS2007014780
OPPOSITIONUS2012122179
OPPOSITIONUS2013184160
OPPOSITIONUS2014154233
OPPOSITIONUS2014328822
OPPOSITIONUS2015238529
OPPOSITIONUS7045601
OPPOSITIONUS7550567
OPPOSITIONUS9371355
OPPOSITIONWO2010019847
OPPOSITIONWO2012038410
OPPOSITIONWO2014085861
OPPOSITIONWO2015136217
OPPOSITIONWO2018007767

Non-Patent Literature (NPL) Citations (18) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- Tracey C. Vlahovic ET AL, "The Human Papillomavirus and Its Role in Plantar Warts", CLINICS IN PODIATRIC MEDICINE AND SURGERY, US, (20160701), vol. 33, no. 3, doi:10.1016/j.cpm.2016.02.003, ISSN 0891-8422, pages 337 - 353, XP055480388
OPPOSITION- Anonymous, "FraglT MZkit ", GENOVIS, (20150101), no. V15.1.1, pages 1 - 3, XP093195206-
OPPOSITION- Anonymous, "Human Fibrinogen", European Pharmacopoeia 11.0, (20110101), page 2995, XP093193872-
OPPOSITION- B. Blombäck , M. Blombäck, "Purification of human and bovine fibrinogen", Arkiv For Kemi, (19560101), vol. 10, no. 29, pages 415 - 443, XP093195188-
OPPOSITION- Blombäck Birger , Margareta Blombäck, "Proceedings of the Swedish Biochemical Society", ACTA chemica scandinavica, (19560101), vol. 10, no. 1, pages 147 - 147, XP093195195-
OPPOSITION- Csl Behring , "Fibrinogen Concentrate (Human) RiaSTAP™", US Package Insert, (20090101), pages 1 - 11, XP093193869-
OPPOSITION- Detmers Frank, Clasen Remke, Van Gemeren Ingeborg, "CaptureSelect™ Technology: Introducing One-Step Selectivity in the Purification of Biological Products", Life technologies, (20130101), pages 1 - 1, XP093195199-
OPPOSITION- Frank W Putna, "Molecular Parameters of Purified Human Plasma Proteins", Frank W Putna, Frank W Putnam, The Plasma Proteins STRUCTURE, FUNCTION, AND GENETIC CONTROL, Academic Press, Inc., (19840101), pages 1 - 5, XP093195204-
OPPOSITION- Hamilton Christopher J, Germann Markus W, "Folding and Base Pairing of a Fibrinogen Specific DNA Aptamer ", Colonial Academic Alliance Undergraduate Research Journal, (20110101), vol. 2, XP093193865-
OPPOSITION- Mayo.E Brown , Fred Rothstein, "Fibrinogen from Human Plasma: Preparation by Precipitation with Heavy-Metal Coordination Complex", Science, (19670224), vol. 155, pages 1017 - 1019, XP093195185-
OPPOSITION- Straughn W., Wagner R.H., "A simple method for preparing fibrinogen", THROMBOSIS AND HAEMOSTASIS, (19660101), pages 198 - 206, XP093193861-
OPPOSITION- Perret Gérald, Santambien Patrick, Boschetti Egisto, "The quest for affinity chromatography ligands: are the molecular libraries the right source?", Journal of separation science, DE , (20150801), vol. 38, no. 15, doi:10.1002/jssc.201500285, ISSN 1615-9306, pages 2559 - 2572, XP093195207
OPPOSITION- Gerard Marguerie, "THE BINDING OF CALCIUM TO FIBRINOGEN: INFLUENCE ON THE CLOTTING PROCESS", Biochimica et Biophysica Acta, (1979), vol. 579, doi:10.1016/0005-2795(79)90093-X, XP023384131
OPPOSITION- Smuc Tina; Ahn Il-Young; Ulrich Hen, "Nucleic acid aptamers as high affinity ligands in biotechnology and biosensorics", Journal of Pharmaceutical and Biomedical Analysis, Elsevier B.V., AMSTERDAM, NL, AMSTERDAM, NL , (20130328), vol. 81, doi:10.1016/j.jpba.2013.03.014, ISSN 0731-7085, pages 210 - 217, XP028546535
OPPOSITION- Neisser-Svae Andrea; Hegener Oliver; Görlinger Klaus, "Differences in the biochemical composition of three plasma derived human fibrinogen concentrates", THROMBOSIS RESEARCH, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20210706), vol. 205, doi:10.1016/j.thromres.2021.06.020, ISSN 0049-3848, pages 44 - 46, XP086722437
OPPOSITION- Minyong Li, "Selecting Aptamers for a Glycoprotein through the Incorporation of the Boronic Acid Moiety", J Am Chem Soc., (20080924), vol. 130, doi:10.1021/ja801510d, XP055043744
OPPOSITION- Masaki Hirashima, Takayuki Imamura, Kentaro Yano, Ryoichi Kawamura, Akihiro Meta, Yoshiyuki Tokieda, Toshihiro Nakashima, "High-level expression and preparation of recombinant human fibrinogen as biopharmaceuticals", Journal of Biochemistry, GB , (20160201), vol. 159, no. 2, doi:10.1093/jb/mvv099, ISSN 0021-924X, pages 261 - 270, XP055368136
OPPOSITION- Masaki Hirashima, Takayuki Imamura, Kentaro Yano, Ryoichi Kawamura, Akihiro Meta, Yoshiyuki Tokieda, Toshihiro Nakashima, "High-level expression and preparation of recombinant human fibrinogen as biopharmaceuticals", Journal of Biochemistry, Oxford University Press, GB, GB , (20160201), vol. 159, no. 2, doi:10.1093/jb/mvv099, ISSN 0021-924X, pages 261 - 270, XP055368136

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents